Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: NovaCardia Inc (wholly owned subsidiary of Merck & Co. Inc)
Woman and Man Max 99 years
NovaCardia Inc (wholly owned subsidiary of Merck & Co. Inc)
Update Il y a 4 ans
A multicentre, randomised, double-blind, placebo-controlled study of the effects of KW-3902 Injectable Emulsion on heart failure signs and symptoms and renal function in subjects with acute heart failure syndrome and renal impairment who are hospitalised for volume overload and require intravenous diuretic therapy
The main objective of this study is to evaluate the effect of KW-3902IV in addition to IV loop diuretic therapy on heart failure signs and symptoms, persistent renal function, morbidity and mortality,...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
NovaCardia Inc (wholly owned subsidiary of Merck & Co. Inc)
Update Il y a 4 ans
A multicentre, randomized, double-blind, placebo controlled study of the effects of KW-3902 Injectable Emulsion on heart failure signs and symptoms, diuresis, renal function, and clinical outcomes in subjects hospitalized with worsening renal function and heart failure requiring intravenous therapy
The main objective of this study is to evaluate the effect of KW-3902 IV, in addition to standard therapy, on the proportion of worsening heart failure and worsening renal function after initiation of...
Country
None
organs
None
Specialty
None
Closed trial
More information